These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 28976864)

  • 21. Correcting for non-compliance in randomized non-inferiority trials with active and placebo control using structural models.
    Wu Y; Zhao L; Hou Y; Li K; Zhou X
    Stat Med; 2015 Mar; 34(6):950-65. PubMed ID: 25534903
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Series: Pragmatic trials and real world evidence: Paper 3. Patient selection challenges and consequences.
    Oude Rengerink K; Kalkman S; Collier S; Ciaglia A; Worsley SD; Lightbourne A; Eckert L; Groenwold RHH; Grobbee DE; Irving EA;
    J Clin Epidemiol; 2017 Sep; 89():173-180. PubMed ID: 28502808
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Compliance in clinical trials.
    Besch CL
    AIDS; 1995 Jan; 9(1):1-10. PubMed ID: 7893432
    [No Abstract]   [Full Text] [Related]  

  • 24. University of Pennsylvania 12th annual conference on statistical issues in clinical trials: Electronic health records in randomized clinical trials-challenges and opportunities (morning panel session).
    Esserman D; Goldstein BA; Levenson M; Platt R; Roe MT; Zeliadt S
    Clin Trials; 2020 Aug; 17(4):405-413. PubMed ID: 32615793
    [No Abstract]   [Full Text] [Related]  

  • 25. [Electronic medical record in clinical trials of effectiveness of drugs integrated in clinical practice].
    Carcas AJ; Abad Santos F; Sánchez Perruca L; Dal-Ré R
    Med Clin (Barc); 2015 Nov; 145(10):452-7. PubMed ID: 25913907
    [No Abstract]   [Full Text] [Related]  

  • 26. Assessment of Pragmatism in Recently Published Randomized Clinical Trials.
    Janiaud P; Dal-Ré R; Ioannidis JPA
    JAMA Intern Med; 2018 Sep; 178(9):1278-1280. PubMed ID: 30039169
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methodological considerations when analysing and interpreting real-world data.
    Stürmer T; Wang T; Golightly YM; Keil A; Lund JL; Jonsson Funk M
    Rheumatology (Oxford); 2020 Jan; 59(1):14-25. PubMed ID: 31834408
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pragmatic design in randomized controlled trials.
    Purgato M; Barbui C; Stroup S; Adams C
    Psychol Med; 2015 Jan; 45(2):225-30. PubMed ID: 25065958
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patient-Centered, Physician-Investigator Friendly Pragmatic Phase Trial Designs-The 4P Model.
    Norris DC; Sen S; Groisberg R; Subbiah V
    Mayo Clin Proc; 2020 Nov; 95(11):2566-2568. PubMed ID: 33153645
    [No Abstract]   [Full Text] [Related]  

  • 30. Proceedings of the University of Pennsylvania eighth annual conference on statistical issues in clinical trials: Statistical issues in pragmatic clinical trials.
    Ellenberg SS; Ellenberg JH
    Clin Trials; 2016 Oct; 13(5):469-70. PubMed ID: 27630247
    [No Abstract]   [Full Text] [Related]  

  • 31. Intention-to-treat analysis: protecting the integrity of randomization.
    Mahaniah KJ; Rao G
    J Fam Pract; 2004 Aug; 53(8):644. PubMed ID: 15298838
    [No Abstract]   [Full Text] [Related]  

  • 32. University of Pennsylvania eighth annual conference on statistical issues in clinical trials: Pragmatic clinical trials (afternoon panel).
    Bellamy S; DeLong E; Erwin R; O'Neill R
    Clin Trials; 2016 Oct; 13(5):527-36. PubMed ID: 27430712
    [No Abstract]   [Full Text] [Related]  

  • 33. Intention-to-treat in randomized controlled trials: recommendations for a total trial strategy.
    Polit DF; Gillespie BM
    Res Nurs Health; 2010 Aug; 33(4):355-68. PubMed ID: 20645423
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intention to treat analysis and per protocol analysis: complementary information.
    Prescrire Int; 2012 Dec; 21(133):304-6. PubMed ID: 23373104
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Compliance in clinical trials: impact on design, analysis and interpretation.
    Pledger GW
    Epilepsy Res Suppl; 1988; 1():125-33. PubMed ID: 3072187
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pros and cons of pragmatic clinical trials.
    Lurie JD; Morgan TS
    J Comp Eff Res; 2013 Jan; 2(1):53-8. PubMed ID: 24236521
    [TBL] [Abstract][Full Text] [Related]  

  • 37. University of Pennsylvania 8th annual conference on statistical issues in clinical trials: Pragmatic clinical trials (morning panel).
    Dodd LE; Lantos JD; Pinheiro J
    Clin Trials; 2016 Oct; 13(5):493-503. PubMed ID: 27430711
    [No Abstract]   [Full Text] [Related]  

  • 38. Trials without tribulations: Minimizing the burden of pragmatic research on healthcare systems.
    Larson EB; Tachibana C; Thompson E; Coronado GD; DeBar L; Dember LM; Honda S; Huang SS; Jarvik JG; Nelson C; Septimus E; Simon G; Johnson KE
    Healthc (Amst); 2016 Sep; 4(3):138-41. PubMed ID: 27637816
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Designing pragmatic trials-what can we learn from lessons learned?
    Groenwold RHH; Dekkers OM
    J Clin Epidemiol; 2017 Oct; 90():3-5. PubMed ID: 28629700
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of non-compliance on intent-to-treat analysis of equivalence trials.
    Sheng D; Kim MY
    Stat Med; 2006 Apr; 25(7):1183-99. PubMed ID: 16220491
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.